Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.93 |
| ▸ | LMNA | P02545 | 3/20 | 0.93 |
| ▸ | CCR1 | P32246 | 3/20 | 0.93 |
| ▸ | CCR5 | P51681 | 3/20 | 0.93 |
| ▸ | CCR8 | P51685 | 3/20 | 0.93 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.93 |
| ▸ | POLB | P06746 | 1/20 | 0.93 |
| ▸ | METAP1 | P53582 | 1/20 | 0.93 |
| ▸ | BLM | P54132 | 1/20 | 0.93 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.93 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.93 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.93 |
| ▸ | NPC1 | O15118 | 6/20 | 0.74 |
| ▸ | TP53 | P04637 | 4/20 | 0.74 |
| ▸ | RAB9A | P51151 | 4/20 | 0.74 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.74 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.74 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.74 |
| ▸ | HTT | P42858 | 2/20 | 0.74 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dipyridyl SCHEMBL5145001 | 1.00 | KDM4E (0.93) | KDM4ELMNACCR1CCR5CCR8 | |
| Dipyridyl SCHEMBL27882761 | 1.00 | KDM4E (0.93) | KDM4ELMNACCR1CCR5CCR8 | |
| Dipyridyl SCHEMBL498331 | 1.00 | KDM4E (0.93) | KDM4ELMNACCR1CCR5CCR8 | |
| Dipyridyl SCHEMBL137577 | 1.00 | KDM4E (0.93) | KDM4ELMNACCR1CCR5CCR8 | |
| Dipyridyl SCHEMBL310586 | 1.00 | KDM4E (0.93) | KDM4ELMNACCR1CCR5CCR8 | |
| Dipyridyl SCHEMBL2245805 | 0.97 | KDM4E (0.88) | KDM4ELMNACCR1CCR5CCR8 | |
| Dipyridyl SCHEMBL6037873 | 0.97 | KDM4E (0.88) | KDM4ELMNACCR1CCR5CCR8 | |
| Dipyridyl SCHEMBL8765640 | 0.97 | KDM4E (0.88) | KDM4ELMNACCR1CCR5CCR8 | |
| Dipyridyl SCHEMBL7619601 | 0.97 | KDM4E (0.88) | KDM4ELMNACCR1CCR5CCR8 | |
| Dipyridyl SCHEMBL30984375 | 0.97 | KDM4E (0.88) | KDM4ELMNACCR1CCR5CCR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0628805-B1 | Luminescent optical indicator for measuring the activity of alkali metal ions in a sample solution | AVL MEDICAL INSTR AG (CH) | 1996-09-18 | — | — | EP | claimed |
| US-5464587-A | In blood | AVL MEDICAL INSTRUMENTS AG (CH) | 1995-11-07 | — | — | US | claimed |
| EP-0628805-A1 | Luminescent optical indicator for measuring the activity of alkali metal ions in a sample solution | AVL Medical Instruments AG (CH) | 1994-12-14 | — | — | EP | claimed |
| CN-114062460-A | Preparation method of ultralow-potential electrochemiluminescence gold nanocluster and construction of luminescent system thereof | 山东大学 | 2022-02-18 | — | — | CN | disclosed |
| US-8536333-B2 | Neutral metallic dendrimer complexes | ISIS INNOVATION LIMITED (GB) | 2013-09-17 | — | — | US | disclosed |
| US-20110127496-A1 | Neutral Metallic Dendrimer Complexes | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2011-06-02 | — | — | US | disclosed |
| US-7799917-B2 | Neutral metallic dendrimer complexes | ISIS INNOVATION LIMTED (GB) | 2010-09-21 | — | — | US | disclosed |
| EP-1532158-B1 | NEUTRAL METALLIC DENDRIMER COMPLEXES | ISIS INNOVATION (GB) | 2008-10-15 | — | — | EP | disclosed |
| US-20060119254-A1 | Neutral metallic dendrimer complexes | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2006-06-08 | — | — | US | disclosed |
| EP-1532158-A1 | NEUTRAL METALLIC DENDRIMER COMPLEXES | ISIS INNOVATION LIMITED (GB) | 2005-05-25 | — | — | EP | disclosed |
| WO-2004020448-A1 | NEUTRAL METALLIC DENDRIMER COMPLEXES | ISIS INNOVATION LIMITED (GB) | 2004-03-11 | — | — | WO | disclosed |
| US-6525200-B1 | Fused pyridine and cyclohexane rings and having optionally other substituents; complexing and quantitating such as urea or guanidine | ROCHE DIAGNOSTICS CORPORATION | 2003-02-25 | — | — | US | disclosed |
| WO-2002014465-A2 | MULTICYCLIC AROMATIC COMPOUNDS AND USES THEREOF | ROCHE DIAGNOSTICS CORPORATION (US) | 2002-02-21 | — | — | WO | disclosed |
| US-5541113-A | Method for detecting an analyte using an electrochemical luminescent transition metal label | BECKMAN INSTRUMENTS, INC. (US) | 1996-07-30 | — | — | US | disclosed |
| US-5541113-A | Method for detecting an analyte using an electrochemical luminescent transition metal label | BECKMAN INSTRUMENTS, INC. (US) | 1996-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060119254-A1 | Neutral metallic dendrimer complexes | ZYX, MLX, ZFX | KDM4E 3503/4885LMNA 1636/4885CCR1 751/4885 |
| US-20110127496-A1 | Neutral Metallic Dendrimer Complexes | ZYX, MLX, ZFX | KDM4E 3503/4885LMNA 1636/4885CCR1 751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.